Sofocruz LP Tablet Substitute
RXMylan Pharmaceuticals Pvt Ltd
₹16000
(₹502.86 per unit)
RXZydus Cadila
₹18500
(₹541.79 per unit)
RXAlkem Laboratories Ltd
₹23940.43
(₹701.11 per unit)
RXNatco Pharma Ltd
₹25000
(₹732.14 per unit)
RXStrides Shasun Ltd
₹25000
(₹732.14 per unit)
RXBiocon Ltd
₹26000
(₹761.43 per unit)
RXAbbott India Ltd
₹27500
(₹805.36 per unit)
Patients may explore substitutes in the following scenarios:
Before you switch from Sofocruz LP Tablet to another medicine, here are some important points to keep in mind:
Same salt, different brands:
Most substitutes contain the same active ingredient - LEDIPASVIR-90MG + SOFOSBUVIR-400MG, but the fillers, coating, or manufacturing quality may vary slightly.
Consult your doctor first:
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Watch out for allergies or reactions:
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
Price ≠ effectiveness:
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Check the dosage form and strength:
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Sofocruz LP Tablet is used in the treatment of chronic hepatitis C virus (HCV) infection. The detailed uses of Sofocruz LP Tablet are as follows:
Sofocruz LP Tablet used to treat chronic (long-term) hepatitis C virus infection in adults and children 3 years of age and older. Sofocruz LP Tablet contains the active ingredients ledipasvir and sofosbuvir. Ledipasvir and Sofosbuvir work together to prevent the virus from growing and reproducing. Thus, the infection can be completely eliminated from the body.
The substitutes of Sofocruz LP Tablet contain the same active salt(s) - LEDIPASVIR-90MG + SOFOSBUVIR-400MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.
Switching to a generic substitute medicine in the place of Sofocruz LP Tablet is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.
Generics versions of Sofocruz LP Tablet are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.
Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.
Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.
Substitutes of Sofocruz LP Tablet meet the same safety and efficacy standards as Sofocruz LP Tablet, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.
Yes. Substitutes of Sofocruz LP Tablet may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.
Yes, it’s generally safe to switch between multiple substitutes of Sofocruz LP Tablet if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.
Yes, many people safely use substitutes of Sofocruz LP Tablet for long-term treatment. Just ensure it’s done under medical supervision.
If your symptoms stay under control or lab results remain stable, the substitute for Sofocruz LP Tablet is likely working well. Regular follow-ups with your doctor are important.
Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Sofocruz LP Tablet to its substitute. Always consult your doctor before switching.
Sofocruz LP Tablet is used to treat Chronic hepatitis C virus (HCV) infection.
Sofocruz LP Tablet contains the active ingredients ledipasvir and sofosbuvir. Ledipasvir and Sofosbuvir work together to prevent the virus from growing and reproducing. Thus, the infection can be completely eliminated from the body.
Hepatitis C virus infection is contagious and spreads from one person to another through contact with an infected person’s blood. Therefore, it is recommended to avoid sharing personal items or needles containing an infected person's blood.
In patients receiving continuing HIV therapy, Sofocruz LP Tablet should be used with caution because your doctor may wish to monitor your condition regularly. Tell your doctor if you are taking tenofovir disoproxil fumarate or any medicine containing tenofovir disoproxil fumarate used to treat HIV infection.
Caution should be exercised while using Sofocruz LP Tablet if you currently take or have taken amiodarone in the last few months. So, inform your doctor. If treatment with Sofocruz LP Tablet is needed, you may require additional heart monitoring.